Cited by 5,340Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology StudiesSubstance Abuse Treatment and Outcomes

Neurocircuitry of Addiction

Open access
Koob, George F, Volkow, Nora D·2010·Neuropsychopharmacology

Abstract

Drug addiction is a chronically relapsing disorder that has been characterized by (1) compulsion to seek and take the drug, (2) loss of control in limiting intake, and (3) emergence of a negative emotional state (eg, dysphoria, anxiety, irritability) reflecting a motivational withdrawal syndrome when access to the drug is prevented. Drug addiction has been conceptualized as a disorder that involves elements of both impulsivity and compulsivity that yield a composite addiction cycle composed of three stages: 'binge/intoxication', 'withdrawal/negative affect', and 'preoccupation/anticipation' (craving). Animal and human imaging studies have revealed discrete circuits that mediate the three stages of the addiction cycle with key elements of the ventral tegmental area and ventral striatum as a focal point for the binge/intoxication stage, a key role for the extended amygdala in the withdrawal/negative affect stage, and a key role in the preoccupation/anticipation stage for a widely distributed network involving the orbitofrontal cortex-dorsal striatum, prefrontal cortex, basolateral amygdala, hippocampus, and insula involved in craving and the cingulate gyrus, dorsolateral prefrontal, and inferior frontal cortices in disrupted inhibitory control. The transition to addiction involves neuroplasticity in all of these structures that may begin with changes in the mesolimbic dopamine system and a cascade of neuroadaptations from the ventral striatum to dorsal striatum and orbitofrontal cortex and eventually dysregulation of the prefrontal cortex, cingulate gyrus, and extended amygdala. The delineation of the neurocircuitry of the evolving stages of the addiction syndrome forms a heuristic basis for the search for the molecular, genetic, and neuropharmacological neuroadaptations that are key to vulnerability for developing and maintaining addiction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2009.110

Cites

252 of 252 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Imaging studies show that cocaine craving cues increase dopamine release in the striatum, amygdala, and prefrontal cortex and opioid peptides in the anterior cingulate and frontal cortex.

    “Imaging studies have also revealed that cues associated with cocaine craving increase dopamine release in the striatum, amygdala, and prefrontal cortex (anterior cingulate and medial orbitofrontal cortex) and opioid peptides in the anterior cingulate and frontal cortex.9,31,106,107”

    From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [9]

    The Ventral Striatum/Dorsal Striatum/Thalamus section (page not provided) reports that drug-associated cues increase dopamine in the dorsal striatum and that the increase correlates with craving. It also links the amygdala and prefrontal cortex to cue-induced craving, but does not report cue-induced dopamine release in those regions. The cited passages do not support increased opioid peptides in the anterior cingulate or frontal cortex. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The amygdala mediates the shift to both negative reinforcement and negative emotional states during withdrawal, which play a key role in addiction.

    “The amygdala also mediates the shift to both negative rein forcement and negative emotional states during withdrawal, which play a key role in addiction (Koob and Volkow, 2010).”

    From Age-dependent Effects of Tobacco Smoke and Nicotine on Cognition and the Brain: A Systematic Review of the Human and Animal Literature Comparing Adolescents and Adults. (2023) · cites this paper as Koob and Volkow, 2010

    In “Withdrawal/Negative Affect Stage” (page unavailable), the paper says the extended amygdala may help produce negative emotional states that promote negative reinforcement in addiction. The claim makes this proposed role definite and calls the structure simply the amygdala, whereas the paper specifies the extended amygdala, which includes other regions. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The mesolimbic dopamine system becomes compromised after chronic administration of virtually all drugs of abuse, including opioids and alcohol.

    “Nevertheless, what is also evident is that the mesolimbic dopamine system becomes compromised after the chronic administration of virtually all drugs of abuse, including opioids and alcohol (Koob and Volkow, 2010;Diana, 2011).”

    From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Volkow, 2010

    The Withdrawal/Negative Affect Stage section reports reduced mesolimbic dopamine activity during acute withdrawal from all major drugs of abuse in animal studies. It also describes compromised dopamine function as a hypothesis concerning particular phases of addiction. The claim omits the withdrawal and animal-study qualifiers, presenting the effect as a general consequence of chronic administration. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Neuroinflammatory signaling pathways in the central nervous system contribute to neuroadaptive processes that mediate dysregulation of hyperkatifeia associated with the withdrawal/negative affect stage of the addiction cycle.

    “Neuroinflammatory signaling pathways in the central nervous system are also hypothesized to contribute to neuroadaptive processes that mediate the dysregulation of hyperkatifeia that is associated with the withdrawal/negative affect stage of the addiction cycle (Koob and Volkow, 2010;Crews and Vetreno, 2016).”

    From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Volkow, 2010

    The Withdrawal/Negative Affect Stage section describes neuroadaptations involving brain stress systems and negative emotional states during withdrawal. It does not identify neuroinflammatory signaling pathways as contributors to those processes or use the term “hyperkatifeia”; the molecular-plasticity passages discuss other signaling mechanisms instead. Pages are not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Impulsivity is a core predictor of addictive behaviors and of negative outcomes associated with addiction.

    “Extant literature has highlighted impulsivity as a core predictor of addictive behaviors and negative outcomes associated with addiction (DeVito et al., 2020; Koob & Volkow, 2010).”

    From Problematic social media use and inhibitory control among post-secondary students (2025) · cites this paper as Koob & Volkow, 2010

    The Cognitive Control section calls impulse control one of the most robust cognitive risk factors for substance use disorders, supporting the addiction-risk part of the claim. The Withdrawal/Negative Affect section hypothesizes that impaired inhibitory control and impulsivity contribute to relapse, but does not establish impulsivity as a core predictor of negative outcomes generally. Page numbers were not available in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Press Washington, DC 4th edn
  2. Hebb DO Textbook of Psychology 1972 WB Saunders Philadelphia 3rd edn

Cited by

Sorted by citations

Authors
Koob, G. F., & Volkow, N. D.
Affiliations
  • Scripps Research Institute (US)
  • National Institute on Drug Abuse (US)
Corresponding author
Koob, George F
Venue
Neuropsychopharmacology
Published
2009-08-26
Volume
35
Issue
1
Pages
217-238
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2066848874
Cited by
5,340
References
252
Citations by year
2026: 257 · 2025: 333 · 2024: 319 · 2023: 357 · 2022: 307 · 2021: 352 · 2020: 365 · 2019: 313 · 2018: 340 · 2017: 354 · 2016: 399 · 2015: 374 · 2014: 353 · 2013: 345 · 2012: 267
FWCI
15.87
Type
journal article
Language
en
Update notices
erratum (2010-01-13)
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Tobacco-Related Disease Research Program
  • National Institutes of Health (AA06420, AA08459, DK-26741)
  • National Institute on Alcohol Abuse and Alcoholism (R01AA008459, AA12602, AA-06420, AA-08459, P50AA006420, R37AA008459, R01AA012602, P60AA006420)
  • National Institute on Drug Abuse (R01DA010072, DA04043, DA04398, DA-10072, AA06420, R01DA004398, R01DA004043)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 26741, P01DK026741)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
drug addiction, neurocircuitry, addiction cycle, withdrawal, craving, ventral tegmental area, ventral striatum, extended amygdala, orbitofrontal cortex, prefrontal cortex, mesolimbic dopamine system, neuroplasticity, impulsivity, compulsivity, inhibitory control, addiction vulnerability
MeSH terms
Animals, Brain, Humans, Models, Neurological, Neural Pathways, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review